• 9576 Citations
  • 50 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Chemoprevention Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Mouth Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

10 Citations (Scopus)

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Borghaei, H., Langer, C. J., Gadgeel, S., Papadimitrakopoulou, V. A., Patnaik, A., Powell, S. F., Gentzler, R. D., Martins, R. G., Stevenson, J. P., Jalal, S. I., Panwalkar, A., Yang, J. C. H., Gubens, M., Sequist, L. V., Awad, M. M., Fiore, J., Saraf, S., Keller, S. M. & Gandhi, L., Jan 1 2019, In : Journal of Thoracic Oncology. 14, 1, p. 124-129 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Survival
Therapeutics

An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer

Haynes, B. C., Blidner, R. A., Cardwell, R. D., Zeigler, R., Gokul, S., Thibert, J. R., Chen, L., Fujimoto, J., Papadimitrakopoulou, V. A., Wistuba, I. I. & Latham, G. J., Jun 1 2019, In : Translational Oncology. 12, 6, p. 836-845 10 p.

Research output: Contribution to journalArticle

Open Access
Gene Fusion
Lung Neoplasms
RNA
Mutation
Workflow

Correction to: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer (Nature Communications, (2018), 9, 1, (3114), 10.1038/s41467-018-05327-w)

Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L., Yang, L., Lv, J., Guo, Z., Jia, H., Chu, Y., Liu, T., Chen, M., Byers, L. A., Roarty, E., Lam, V. K., Papadimitrakopoulou, V. A., Wistuba, I. I., Heymach, J. V., Glisson, B. S. & 7 othersLiao, Z., Lee, J-K. J., Futreal, P. A., Zhang, S., Xia, X., Zhang, J. & Wang, J., Dec 1 2019, In : Nature communications. 10, 1, 552.

Research output: Contribution to journalComment/debate

Open Access
document markup languages
HTML
Small Cell Lung Carcinoma
lungs
Labels

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)

Elamin, Y. Y., Gomez, D., Antonoff, M. B., Robichaux, J. P., Tran, H. T., Shorter, M. K., Bohac, J. M., Negrao, M. V., Le, X., Rinsurogkawong, W., Lewis, J., Lacerda, L., Roarty, E. B., Swisher, S. G., Roth, J. A., Zhang, J., Papadimitrakopoulou, V. A. & Heymach, J. V., Jan 1 2019, In : Clinical Lung Cancer. 20, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
Disease-Free Survival
Neoplasm Genes
HLA Antigens
Tumor Burden
Non-Small Cell Lung Carcinoma
Genotype